Multiple sources have recently suggested MPS1-inhibition to be a viable treatment option for brain tumors, either alone [31,32] or in combination with other therapeutics such as radiation therapy [30], chemotherapy [15], or TTFields [14]. Here, TTK is linked to brain neoplasm.